261 results on '"Drummer, Heidi E."'
Search Results
2. Antibody mechanisms of protection against malaria in RTS,S-vaccinated children: a post-hoc serological analysis of phase 2 trial
3. COVID-19 Adenoviral Vector Vaccination Elicits a Robust Memory B Cell Response with the Capacity to Recognize Omicron BA.2 and BA.5 Variants
4. B-cell characteristics define HCV reinfection outcome
5. Accuracy and precision of a point of care SARS-CoV-2 antigen rapid diagnostic test assessed in an Australian cohort
6. An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine Development
7. Infectious KoRV-related retroviruses circulating in Australian bats
8. Serological responses and clinical outcomes following a three‐dose primary COVID‐19 vaccine schedule in kidney transplant recipients and people on dialysis.
9. Enhancing the antigenicity and immunogenicity of monomeric forms of hepatitis C virus E2 for use as a preventive vaccine
10. Injecting drug use and hepatitis C virus infection independently increase biomarkers of inflammatory disease risk which are incompletely restored by curative direct-acting antiviral therapy
11. Bridging the gap: A new tool to down select HCV vaccine candidates.
12. Dimeric immunoglobulin A as a novel diagnostic marker of measles infection
13. Joint statement in support of hepatitis C human challenge studies
14. Third dose COVID-19 mRNA vaccine enhances IgG4 isotype switching and recognition of Omicron subvariants by memory B cells after with mRNA but not adenovirus priming
15. Serological assays to measure dimeric IgA antibodies in SARS‐CoV‐2 infections
16. Enhanced stability of the SARS CoV-2 spike glycoprotein following modification of an alanine cavity in the protein core
17. Joint statement in support of hepatitis C human challenge studies
18. The case for a universal hepatitis C vaccine to achieve hepatitis C elimination
19. COVID-19 adenoviral vector vaccination elicits a robust memory B cell response with the capacity to recognize Omicron BA.2 and BA.5 variants
20. Validation of a novel point‐of‐care test for alanine aminotransferase measurement: A pilot cohort study
21. B Cell Signatures and Antibody Imprinting Define HCV Reinfection Outcome
22. The second COVID‐19 mRNA vaccine dose enhances the capacity of Spike‐specific memory B cells to bind Omicron BA.2
23. Enhanced stability of the SARS CoV-2 spike glycoprotein trimer following modification of an alanine cavity in the protein core
24. Validation of novel point‐of‐care test for alanine aminotransferase measurement: A pilot cohort study
25. Double-dose mRNA vaccination to SARS-CoV-2 progressively increases recognition of variants-of-concern by Spike RBD-specific memory B cells
26. Point-of-Care Diagnostics for Diagnosis of Active Syphilis Infection: Needs, Challenges and the Way Forward
27. A pan‐genotype hepatitis C virus viral vector vaccine generates T cells and neutralizing antibodies in mice
28. Virus-Like Particles Containing the E2 Core Domain of Hepatitis C Virus Generate Broadly Neutralizing Antibodies in Guinea Pigs
29. An antigenically diverse, representative panel of envelope glycoproteins for HCV vaccine development
30. The second COVID‐19 mRNA vaccine dose enhances the capacity of Spike‐specific memory B cells to bind Omicron BA.2.
31. A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2
32. The Inaugural Australian Centre for Hepatitis Virology Public Panel Discussion on Viral Hepatitis Research—Lessons in Scientific Community Outreach
33. Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection
34. Antibodies to the high-density lipoprotein receptor SR-B1 potently inhibit hepatitis C virus replication in vivo: New avenues for preventing reinfection of the liver following transplantation
35. To Include or Occlude: Rational Engineering of HCV Vaccines for Humoral Immunity
36. Reanalysis of the Pfizer mRNA BNT162b2 SARS-CoV-2 vaccine data fails to find any increased efficacy following the boost: Implications for vaccination policy and our understanding of the mode of action
37. Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence
38. Rapid and lasting generation of B-cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 disease and convalescence
39. 10th Lorne Infection and Immunity Conference 2020
40. Tenth Scientific Biennial Meeting of the Australasian Virology Society—AVS10 2019
41. Striving for Hepatitis C Elimination: The Role of a Vaccine
42. B cell immunodominance in primary hepatitis C virus infection
43. TCD8 response in diverse outcomes of recurrent exposure to hepatitis C virus
44. Conjugation of an scFab domain to the oligomeric HIV envelope protein for use in immune targeting
45. Antibody Responses to a Quadrivalent Hepatitis C Viral-Like Particle Vaccine Adjuvanted with Toll-Like Receptor 2 Agonists
46. Escape of Hepatitis C Virus from Epitope I Neutralization Increases Sensitivity of Other Neutralization Epitopes
47. Distinct functions for the membrane-proximal ectodomain region (MPER) of HIV-1 gp41 in cell-free and cell–cell viral transmission and cell–cell fusion
48. A new panel of epitope mapped monoclonal antibodies recognising the prototypical tetraspanin CD81
49. A new panel of epitope mapped monoclonal antibodies recognising the prototypical tetraspanin CD81
50. An Optimized Hepatitis C Virus E2 Glycoprotein Core Adopts a Functional Homodimer That Efficiently Blocks Virus Entry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.